How Bristol-Myers Squibb's new Peninsula digs boost its battle to beat cancer

Cancer's zigs and zags to avoid detection and destruction may come to a dead end in a 62,000-square-foot Redwood City building. Bristol-Myers Squibb Co. opened the third of its three-structure West Coast research center, where the New York-based drug giant has zeroed in on antibodies that stoke the immune system's battle against cancer. But while so-called cancer immunotherapies, such as BMS's Yervoy and Opdivo, produced s tunning results in some patients, most don't respond and some relapse. That's…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news